nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzphetamine—SLC6A3—attention deficit hyperactivity disorder	0.418	0.505	CbGaD
Benzphetamine—ADRA2A—attention deficit hyperactivity disorder	0.409	0.495	CbGaD
Benzphetamine—SLC6A2—locus ceruleus—attention deficit hyperactivity disorder	0.0113	0.221	CbGeAlD
Benzphetamine—SLC6A2—autonomic nervous system—attention deficit hyperactivity disorder	0.00599	0.117	CbGeAlD
Benzphetamine—SLC18A2—forebrain—attention deficit hyperactivity disorder	0.00229	0.0448	CbGeAlD
Benzphetamine—SLC6A3—forebrain—attention deficit hyperactivity disorder	0.00173	0.0339	CbGeAlD
Benzphetamine—POR—midbrain—attention deficit hyperactivity disorder	0.00158	0.0311	CbGeAlD
Benzphetamine—SLC18A2—midbrain—attention deficit hyperactivity disorder	0.00151	0.0296	CbGeAlD
Benzphetamine—SLC6A2—forebrain—attention deficit hyperactivity disorder	0.0014	0.0274	CbGeAlD
Benzphetamine—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.0013	0.0254	CbGeAlD
Benzphetamine—SLC18A2—nervous system—attention deficit hyperactivity disorder	0.00124	0.0243	CbGeAlD
Benzphetamine—POR—cerebellum—attention deficit hyperactivity disorder	0.00123	0.024	CbGeAlD
Benzphetamine—SLC18A2—central nervous system—attention deficit hyperactivity disorder	0.00119	0.0234	CbGeAlD
Benzphetamine—SLC18A2—cerebellum—attention deficit hyperactivity disorder	0.00117	0.0229	CbGeAlD
Benzphetamine—SLC6A3—midbrain—attention deficit hyperactivity disorder	0.00114	0.0224	CbGeAlD
Benzphetamine—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.0011	0.0215	CbGeAlD
Benzphetamine—POR—brain—attention deficit hyperactivity disorder	0.000995	0.0195	CbGeAlD
Benzphetamine—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.000986	0.0193	CbGeAlD
Benzphetamine—SLC18A2—brain—attention deficit hyperactivity disorder	0.000949	0.0186	CbGeAlD
Benzphetamine—SLC6A3—nervous system—attention deficit hyperactivity disorder	0.000939	0.0184	CbGeAlD
Benzphetamine—SLC6A3—central nervous system—attention deficit hyperactivity disorder	0.000904	0.0177	CbGeAlD
Benzphetamine—SLC6A3—cerebellum—attention deficit hyperactivity disorder	0.000883	0.0173	CbGeAlD
Benzphetamine—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.000869	0.0171	CbGeAlD
Benzphetamine—SLC6A2—nervous system—attention deficit hyperactivity disorder	0.000757	0.0149	CbGeAlD
Benzphetamine—SLC6A2—central nervous system—attention deficit hyperactivity disorder	0.000729	0.0143	CbGeAlD
Benzphetamine—SLC6A3—brain—attention deficit hyperactivity disorder	0.000718	0.0141	CbGeAlD
Benzphetamine—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.000704	0.0138	CbGeAlD
Benzphetamine—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.000678	0.0133	CbGeAlD
Benzphetamine—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.000663	0.013	CbGeAlD
Benzphetamine—ADRA2A—midbrain—attention deficit hyperactivity disorder	0.000651	0.0128	CbGeAlD
Benzphetamine—ADRA1A—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.000592	0.00516	CbGpPWpGaD
Benzphetamine—ADRA1A—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.000584	0.00509	CbGpPWpGaD
Benzphetamine—Pargyline—MAOA—attention deficit hyperactivity disorder	0.00058	0.0828	CrCbGaD
Benzphetamine—SLC6A2—brain—attention deficit hyperactivity disorder	0.000579	0.0114	CbGeAlD
Benzphetamine—ADRA2A—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.000577	0.00503	CbGpPWpGaD
Benzphetamine—ADRA1A—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.000562	0.0049	CbGpPWpGaD
Benzphetamine—ADRA2A—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.000559	0.00488	CbGpPWpGaD
Benzphetamine—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.000558	0.0109	CbGeAlD
Benzphetamine—ADRA1A—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.000544	0.00475	CbGpPWpGaD
Benzphetamine—ADRA2A—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.000543	0.00473	CbGpPWpGaD
Benzphetamine—ADRA1A—brain—attention deficit hyperactivity disorder	0.000538	0.0106	CbGeAlD
Benzphetamine—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.000537	0.0105	CbGeAlD
Benzphetamine—ADRA2A—nervous system—attention deficit hyperactivity disorder	0.000535	0.0105	CbGeAlD
Benzphetamine—ADRA2A—Regulation of insulin secretion—ADRA2C—attention deficit hyperactivity disorder	0.000531	0.00463	CbGpPWpGaD
Benzphetamine—ADRA1A—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.000522	0.00455	CbGpPWpGaD
Benzphetamine—ADRA2A—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.000522	0.00455	CbGpPWpGaD
Benzphetamine—ADRA2A—central nervous system—attention deficit hyperactivity disorder	0.000515	0.0101	CbGeAlD
Benzphetamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.000507	0.00442	CbGpPWpGaD
Benzphetamine—ADRA1A—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.000506	0.00441	CbGpPWpGaD
Benzphetamine—ADRA2A—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.000506	0.00441	CbGpPWpGaD
Benzphetamine—ADRA2A—cerebellum—attention deficit hyperactivity disorder	0.000504	0.00988	CbGeAlD
Benzphetamine—ADRA1A—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.000497	0.00434	CbGpPWpGaD
Benzphetamine—ADRA1A—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.000491	0.00428	CbGpPWpGaD
Benzphetamine—ADRA2A—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.000485	0.00423	CbGpPWpGaD
Benzphetamine—ADRA2A—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00047	0.0041	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.000464	0.00405	CbGpPWpGaD
Benzphetamine—ADRA1A—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.000458	0.00399	CbGpPWpGaD
Benzphetamine—ADRA2A—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.000456	0.00398	CbGpPWpGaD
Benzphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000445	0.00388	CbGpPWpGaD
Benzphetamine—Methamphetamine—ADRA2C—attention deficit hyperactivity disorder	0.000442	0.0631	CrCbGaD
Benzphetamine—CYP2B6—brain—attention deficit hyperactivity disorder	0.000427	0.00837	CbGeAlD
Benzphetamine—ADRA2A—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.000425	0.00371	CbGpPWpGaD
Benzphetamine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000421	0.00827	CbGeAlD
Benzphetamine—Phenoxybenzamine—ADRA2C—attention deficit hyperactivity disorder	0.000419	0.0598	CrCbGaD
Benzphetamine—ADRA2A—Integration of energy metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000418	0.00364	CbGpPWpGaD
Benzphetamine—ADRA2A—brain—attention deficit hyperactivity disorder	0.000409	0.00803	CbGeAlD
Benzphetamine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000406	0.00796	CbGeAlD
Benzphetamine—SLC18A2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000399	0.00348	CbGpPWpGaD
Benzphetamine—Bepridil—CACNA1C—attention deficit hyperactivity disorder	0.000395	0.0565	CrCbGaD
Benzphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000395	0.00344	CbGpPWpGaD
Benzphetamine—Diphenylpyraline—SLC6A3—attention deficit hyperactivity disorder	0.000388	0.0554	CrCbGaD
Benzphetamine—ADRA1A—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.000381	0.00332	CbGpPWpGaD
Benzphetamine—ADRA2A—Regulation of insulin secretion—CACNB2—attention deficit hyperactivity disorder	0.000367	0.0032	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.000356	0.0031	CbGpPWpGaD
Benzphetamine—ADRA2A—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.000354	0.00309	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000343	0.00299	CbGpPWpGaD
Benzphetamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.000341	0.00297	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000336	0.00293	CbGpPWpGaD
Benzphetamine—ADRA2A—Regulation of insulin secretion—CACNA1C—attention deficit hyperactivity disorder	0.000335	0.00292	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.000324	0.00283	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000321	0.0028	CbGpPWpGaD
Benzphetamine—ADRA1A—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00032	0.00279	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000319	0.00278	CbGpPWpGaD
Benzphetamine—SLC18A2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000306	0.00266	CbGpPWpGaD
Benzphetamine—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.000303	0.00264	CbGpPWpGaD
Benzphetamine—ADRA2A—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.000298	0.0026	CbGpPWpGaD
Benzphetamine—Benzatropine—SLC6A3—attention deficit hyperactivity disorder	0.000297	0.0425	CrCbGaD
Benzphetamine—ADRA2A—Regulation of insulin secretion—SNAP25—attention deficit hyperactivity disorder	0.000293	0.00256	CbGpPWpGaD
Benzphetamine—Selegiline—MAOA—attention deficit hyperactivity disorder	0.00029	0.0414	CrCbGaD
Benzphetamine—ADRA2A—Integration of energy metabolism—CACNB2—attention deficit hyperactivity disorder	0.000288	0.00251	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000284	0.00248	CbGpPWpGaD
Benzphetamine—SLC6A2—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.000276	0.00241	CbGpPWpGaD
Benzphetamine—ADRA2A—Integration of energy metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000264	0.0023	CbGpPWpGaD
Benzphetamine—SLC18A2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000263	0.00229	CbGpPWpGaD
Benzphetamine—Dextroamphetamine—SLC6A3—attention deficit hyperactivity disorder	0.000258	0.0368	CrCbGaD
Benzphetamine—SLC6A2—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.000246	0.00214	CbGpPWpGaD
Benzphetamine—SLC6A3—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.000244	0.00213	CbGpPWpGaD
Benzphetamine—SLC18A2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000244	0.00213	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000242	0.00211	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00024	0.00209	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000238	0.00207	CbGpPWpGaD
Benzphetamine—ADRA2A—Integration of energy metabolism—SNAP25—attention deficit hyperactivity disorder	0.000231	0.00201	CbGpPWpGaD
Benzphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00023	0.00201	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.000229	0.00199	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000226	0.00197	CbGpPWpGaD
Benzphetamine—Methamphetamine—MAOA—attention deficit hyperactivity disorder	0.000223	0.0319	CrCbGaD
Benzphetamine—Modafinil—SLC6A3—attention deficit hyperactivity disorder	0.00022	0.0314	CrCbGaD
Benzphetamine—SLC18A2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000218	0.0019	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.000218	0.0019	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000217	0.00189	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000216	0.00188	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.000213	0.00186	CbGpPWpGaD
Benzphetamine—ADRA1A—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.000213	0.00186	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000211	0.00184	CbGpPWpGaD
Benzphetamine—Atomoxetine—HTR1B—attention deficit hyperactivity disorder	0.00021	0.0299	CrCbGaD
Benzphetamine—Amphetamine—SLC6A3—attention deficit hyperactivity disorder	0.000208	0.0297	CrCbGaD
Benzphetamine—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000205	0.00178	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000204	0.00178	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000202	0.00176	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000201	0.00175	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.000198	0.00172	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000196	0.00171	CbGpPWpGaD
Benzphetamine—Methamphetamine—SLC6A3—attention deficit hyperactivity disorder	0.000192	0.0275	CrCbGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000191	0.00167	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00019	0.00166	CbGpPWpGaD
Benzphetamine—Atomoxetine—SLC6A3—attention deficit hyperactivity disorder	0.000189	0.027	CrCbGaD
Benzphetamine—Methamphetamine—ADRA2A—attention deficit hyperactivity disorder	0.000189	0.0269	CrCbGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000186	0.00162	CbGpPWpGaD
Benzphetamine—Cyclobenzaprine—HTR2A—attention deficit hyperactivity disorder	0.000185	0.0264	CrCbGaD
Benzphetamine—SLC18A2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000185	0.00161	CbGpPWpGaD
Benzphetamine—SLC18A2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000184	0.0016	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000182	0.00159	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000182	0.00159	CbGpPWpGaD
Benzphetamine—Phenoxybenzamine—ADRA2A—attention deficit hyperactivity disorder	0.000179	0.0255	CrCbGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000173	0.00151	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00017	0.00148	CbGpPWpGaD
Benzphetamine—Promazine—DRD4—attention deficit hyperactivity disorder	0.000164	0.0235	CrCbGaD
Benzphetamine—SLC6A3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000157	0.00137	CbGpPWpGaD
Benzphetamine—Trimipramine—SLC6A3—attention deficit hyperactivity disorder	0.000156	0.0222	CrCbGaD
Benzphetamine—Amphetamine—SLC6A4—attention deficit hyperactivity disorder	0.000155	0.0222	CrCbGaD
Benzphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000155	0.00135	CbGpPWpGaD
Benzphetamine—Amphetamine—DRD2—attention deficit hyperactivity disorder	0.000154	0.0221	CrCbGaD
Benzphetamine—Trimipramine—ADRA2A—attention deficit hyperactivity disorder	0.000153	0.0218	CrCbGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.000148	0.00129	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000148	0.00129	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000146	0.00127	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000144	0.00126	CbGpPWpGaD
Benzphetamine—Methamphetamine—SLC6A4—attention deficit hyperactivity disorder	0.000144	0.0205	CrCbGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000143	0.00125	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000142	0.00124	CbGpPWpGaD
Benzphetamine—Atomoxetine—SLC6A4—attention deficit hyperactivity disorder	0.000142	0.0202	CrCbGaD
Benzphetamine—Promazine—DRD1—attention deficit hyperactivity disorder	0.000139	0.0199	CrCbGaD
Benzphetamine—ADRA1A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000139	0.00121	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000137	0.0012	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000132	0.00115	CbGpPWpGaD
Benzphetamine—Promazine—ADRA2A—attention deficit hyperactivity disorder	0.000129	0.0185	CrCbGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.000129	0.00113	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000129	0.00113	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000129	0.00112	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000126	0.0011	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00012	0.00105	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00012	0.00104	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000119	0.00104	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.000118	0.00103	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000118	0.00102	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000117	0.00102	CbGpPWpGaD
Benzphetamine—Trimipramine—SLC6A4—attention deficit hyperactivity disorder	0.000116	0.0166	CrCbGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.000116	0.00101	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000116	0.00101	CbGpPWpGaD
Benzphetamine—Trimipramine—DRD2—attention deficit hyperactivity disorder	0.000116	0.0165	CrCbGaD
Benzphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000114	0.000995	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000113	0.000984	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000113	0.000983	CbGpPWpGaD
Benzphetamine—Promethazine—DRD2—attention deficit hyperactivity disorder	0.000112	0.0159	CrCbGaD
Benzphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000111	0.000971	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000111	0.000968	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000111	0.000963	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00011	0.000962	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00011	0.000955	CbGpPWpGaD
Benzphetamine—CYP2B6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00011	0.000955	CbGpPWpGaD
Benzphetamine—Atomoxetine—HTR2A—attention deficit hyperactivity disorder	0.000109	0.0155	CrCbGaD
Benzphetamine—CYP2B6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000109	0.000948	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000109	0.000946	CbGpPWpGaD
Benzphetamine—CYP2B6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000108	0.000942	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000108	0.000941	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000105	0.000917	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000105	0.000916	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000105	0.000913	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000103	0.000896	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000103	0.000895	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000101	0.000879	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	9.95e-05	0.000868	CbGpPWpGaD
Benzphetamine—Promazine—DRD2—attention deficit hyperactivity disorder	9.81e-05	0.014	CrCbGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	9.78e-05	0.000853	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	9.76e-05	0.000851	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	9.66e-05	0.000842	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	9.63e-05	0.000839	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	9.55e-05	0.000832	CbGpPWpGaD
Benzphetamine—ADRA1A—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	9.52e-05	0.00083	CbGpPWpGaD
Benzphetamine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	9.3e-05	0.000811	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	9.25e-05	0.000806	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	9e-05	0.000785	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	8.98e-05	0.000782	CbGpPWpGaD
Benzphetamine—Trimipramine—HTR2A—attention deficit hyperactivity disorder	8.95e-05	0.0128	CrCbGaD
Benzphetamine—ADRA2A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	8.95e-05	0.00078	CbGpPWpGaD
Benzphetamine—Promethazine—HTR2A—attention deficit hyperactivity disorder	8.62e-05	0.0123	CrCbGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	8.51e-05	0.000742	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	8.42e-05	0.000734	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	8.36e-05	0.000729	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	8.01e-05	0.000699	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	7.88e-05	0.000687	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	7.85e-05	0.000684	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	7.83e-05	0.000682	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	7.82e-05	0.000682	CbGpPWpGaD
Benzphetamine—Promazine—HTR2A—attention deficit hyperactivity disorder	7.58e-05	0.0108	CrCbGaD
Benzphetamine—ADRA1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	7.58e-05	0.000661	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	7.45e-05	0.000649	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	7.45e-05	0.000649	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	7.36e-05	0.000641	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	7.36e-05	0.000641	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	7.3e-05	0.000636	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	7.28e-05	0.000634	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	7.27e-05	0.000634	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	7.13e-05	0.000621	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	7.04e-05	0.000614	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	6.85e-05	0.000597	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	6.84e-05	0.000596	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	6.84e-05	0.000596	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	6.76e-05	0.000589	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	6.62e-05	0.000577	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	6.41e-05	0.000559	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	6.37e-05	0.000555	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	6.3e-05	0.000549	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.96e-05	0.000519	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	5.86e-05	0.000511	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.44e-05	0.000474	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.06e-05	0.000441	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5e-05	0.000436	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	4.98e-05	0.000434	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.94e-05	0.000431	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	4.94e-05	0.000431	CbGpPWpGaD
Benzphetamine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	4.91e-05	0.000428	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.8e-05	0.000418	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.78e-05	0.000416	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.76e-05	0.000415	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.65e-05	0.000405	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.59e-05	0.0004	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.48e-05	0.00039	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.46e-05	0.000389	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.42e-05	0.000385	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.42e-05	0.000385	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.32e-05	0.000377	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.3e-05	0.000375	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.28e-05	0.000373	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.21e-05	0.000367	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.21e-05	0.000367	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.16e-05	0.000362	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.13e-05	0.00036	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.11e-05	0.000358	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.02e-05	0.00035	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.01e-05	0.00035	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.99e-05	0.000348	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.98e-05	0.000347	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.91e-05	0.000341	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.89e-05	0.000339	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.87e-05	0.000338	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.86e-05	0.000337	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.84e-05	0.000335	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.82e-05	0.000333	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.78e-05	0.000329	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.73e-05	0.000325	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.61e-05	0.000315	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.6e-05	0.000314	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.52e-05	0.000307	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.51e-05	0.000306	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—TPH2—attention deficit hyperactivity disorder	3.3e-05	0.000287	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.3e-05	0.000287	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.27e-05	0.000285	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—DPYD—attention deficit hyperactivity disorder	3.24e-05	0.000283	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	3.09e-05	0.000269	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.09e-05	0.000269	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	3.04e-05	0.000265	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.02e-05	0.000263	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.92e-05	0.000254	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.83e-05	0.000246	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.71e-05	0.000236	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.71e-05	0.000236	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.64e-05	0.00023	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.55e-05	0.000222	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.52e-05	0.00022	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.47e-05	0.000215	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.46e-05	0.000215	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.37e-05	0.000207	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.37e-05	0.000207	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.35e-05	0.000205	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.3e-05	0.0002	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.29e-05	0.0002	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.26e-05	0.000197	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.23e-05	0.000194	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.2e-05	0.000192	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.13e-05	0.000186	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	2.11e-05	0.000184	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.08e-05	0.000181	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.07e-05	0.000181	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.04e-05	0.000177	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	2e-05	0.000174	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	1.98e-05	0.000173	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.93e-05	0.000168	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	1.87e-05	0.000163	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.86e-05	0.000162	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.46e-05	0.000127	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	1.4e-05	0.000122	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.4e-05	0.000122	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	1.38e-05	0.00012	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.35e-05	0.000118	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.28e-05	0.000112	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.12e-05	9.79e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.07e-05	9.32e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	8.57e-06	7.47e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	8.51e-06	7.42e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	8.45e-06	7.37e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	8.03e-06	7e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.71e-06	6.72e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.16e-06	6.24e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	3.65e-06	3.18e-05	CbGpPWpGaD
